Cost-Utility Analysis of Atazanavir/Ritonavir 200/100 Mg Versus Atazanavir/Ritonavir 300/100 Mg in Thai Adults with Virologic Suppression

Abstract

Authors

S Taychakhoonavudh N Maneesawangwong T Bunupuradah S Kiertiburanakul T Worrathammasorn P Hadnorntun A Avihingsanon P Chetchotisakd S Emery K Ruxrungtham